VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Recruiting

Transmural HealingVECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Sponsor:

Alimentiv Inc.

Code:

NCT06257706

Conditions

Moderately to Severely Active Crohn's Disease

Crohn Disease

Disease Crohn

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Vedolizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-30. This information was provided to ClinicalTrials.gov by Alimentiv Inc. on 2025-02-21.